17,520 resources
By Version
By Realm
Start Prev Rows 10200 - 10400 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Source(s) |
---|---|---|---|---|---|---|---|---|---|
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.3.4--20200901000000 | HoudingHandhavenCodelijst | active | nl | sct | |||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.3.1--20200901000000 | HoudingVeranderenCodelijst | active | nl | sct | |||
hl7.terminology | R5 | v3-CodeSystemType | CodeSystemType | retired | 2014-03 | uv | tho | ||
hl7.terminology | R5 | contract-data-meaning | ContractDataMeaning | draft | fm | 2020-02 | uv | tho | |
de.netzwerk-universitaetsmedizin.ebm-cpg | R5 | vs-rating-equity | Rating Equity | draft | 2022-09 | uv | internal | ||
de.netzwerk-universitaetsmedizin.ebm-cpg | R5 | vs-rating-feasibility | Rating Feasibility | draft | 2022-09 | uv | internal | ||
signal.core.r4 | R4 | questionnaire-ccars-existence-presenting-problem | Questionnaire CCARS Existence Presenting Problem | draft | 1 | pa | us | ||
hl7.fhir.us.mcode | R4 | mcode-condition-status-trend-vs | Condition Status Trend Value Set | active | 3 | cic | 2025-02 | us | sct |
hl7.fhir.uv.tools | R5 | binding-style | Vocab Binding Style ValueSet | informative | 3 | fhir | 2025-07 | uv | fhir |
hl7.fhir.uv.tools | R5 | snapshot-behavior | Viewing Hints for Rendering Engines (ValueSet) | informative | 2 | fhir | 2025-07 | uv | fhir |
hl7.fhir.uv.tools | R5 | view-hint | Viewing Hints for Rendering Engines (ValueSet) | informative | 0 | fhir | 2025-07 | uv | fhir |
hl7.fhir.uv.tools.r3 | R3 | type-profile-style | Type Profile Style ValueSet | informative | 3 | fhir | 2025-07 | uv | fhir |
hl7.fhir.uv.tools | R5 | extension-style | Extension Style ValueSet | informative | 3 | fhir | 2025-07 | uv | fhir |
hl7.fhir.uv.tools | R5 | matchetype-mode | Matchetype Mode ValueSet | informative | 3 | fhir | 2025-07 | uv | fhir |
hl7.terminology | R5 | v3-HtmlLinkType | HtmlLinkType | active | 2014-03 | uv | tho | ||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.16.4--20200901000000 | HuidskleurScoreCodelijst | active | nl | loinc | |||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.12.4--20200901000000 | HuilenCodelijst | active | nl | oid | |||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.13.4--20200901000000 | HuilenCodelijst | active | nl | oid | |||
hl7.fhir.uv.phenomics-exchange | R4 | PhenotypicModifierValueSet | Phenotypic modifier ValueSet | draft | cic | 2024-06 | uv | gene | |
hl7.terminology | R5 | v3-ObservationDrugIntoleranceType | ObservationDrugIntoleranceType | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ObservationIntoleranceType | ObservationIntoleranceType | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ObservationEnvironmentalIntoleranceType | ObservationEnvironmentalIntoleranceType | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ObservationFoodIntoleranceType | ObservationFoodIntoleranceType | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ObservationNonAllergyIntoleranceType | ObservationNonAllergyIntoleranceType | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ObservationAllergyType | ObservationAllergyType | active | 2014-03 | uv | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.611 | relatedconditions_Asthma I10 | active | 2023-09 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.571 | Allergy to house dust mites I10 | active | 2023-08 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.409 | Hypertension I10 | active | 2023-09 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.38 | relatedconditions_hypertension I10 | active | 2023-09 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.322 | Angina I10 | active | 2023-09 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.252 | relatedconditions_Heart failure I10 | active | 2023-09 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.350 | Coronary artery disease I10 | active | 2023-09 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.439 | relatedconditions_T2DM I10 | active | 2024-03 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.325 | Tachyarrhythmia I10 | active | 2023-09 | us | icd | ||
hl7.fhir.us.davinci-pct | R4 | PCTDiagnosticCodes | PCT ICD-10 Diagnostic Codes | trial-use | fm | 2025-06 | us | icd | |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1147.119 | Inpatient Falls | active | 2024-01 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.23 | Coagulation Disorders | active | 2025-02 | us | icd | ||
de.basisprofil.r4 | R4 | valueset-ICD-10-GM | ICD10GM ValueSet | active | 2025-06 | ||||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.20.7.3--20200901000000 | LocatieICD-O-3Codelijst | active | nl | oid | |||
hl7.eu.fhir.pcsp | R4 | vs-icdo3-morphology-eu-pcsp | ICD-O-3 Morphology | draft | 2025-07 | eu | tho | ||
hl7.eu.fhir.pcsp | R4 | vs-icdo3-topography-eu-pcsp | ICD-O-3 Topography | draft | 2025-07 | eu | tho | ||
hl7.fhir.us.vrdr | R4 | vrdr-icd10-causes-of-death-vs | ICD10 Causes of Death ValueSet | active | pher | 2024-10 | us | icd | |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.88 | Acute Respiratory Failure | active | 2023-04 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.92 | Degenerative Neurological Disorder | active | 2024-01 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.93 | Head and Neck Surgeries with High Risk Airway Compromise | active | 2024-01 | us | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.91 | Neuromuscular Disorder | active | 2024-01 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.89 | Tracheostomy Diagnoses | active | 2022-07 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.136 | Leukemia or Lymphoma | active | 2022-10 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.137 | Liver Disease Moderate to Severe | active | 2022-10 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.20 | Secondary Erythrocytosis Disorder ICD10CM | active | 2022-03 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.79 | Acute Brain or Spinal Injury or Hemorrhage | active | 2024-06 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.105 | Mechanical Ventilation Procedures | active | 2022-05 | us | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.81 | Extracorporeal Membrane Oxygenation | active | 2024-05 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.90 | Tracheostomy Procedures | active | 2023-04 | us | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.86 | Intubation | active | 2022-07 | us | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.41 | All Metastatic Sites ICD910 | active | 2023-10 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.80 | Pulmonary Arterial Thrombectomy | active | 2024-06 | us | cms | ||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.26.3--20200901000000 | StatusNaamICFCodelijst | active | nl | fhir | |||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.26.6--20200901000000 | StatusWaardeICFCodelijst | active | nl | fhir | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.26.3--20171231000000 | StatusNaamICFCodelijst | active | nl | fhir | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.26.6--20171231000000 | StatusWaardeICFCodelijst | active | nl | fhir | |||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.6.1--20200901000000 | SOEPRegelCodeCodelijst | active | nl | icpc | |||
ch.fhir.ig.ch-epr-fhir | R4 | PpqmReferencedPolicySetDefaultProvide | CH PPQm Referenced Policy Set for Default Provide (203) template | active | 2025-05 | ch | ietf | ||
ch.fhir.ig.ch-epr-fhir | R4 | PpqmReferencedPolicySetHcpWithoutDelegation | CH PPQm Referenced Policy Set for Healthcare Professionals without Delegation (301) template | active | 2025-05 | ch | ietf | ||
ch.fhir.ig.ch-epr-fhir | R4 | PpqmReferencedPolicySetHcpWithDelegation | CH PPQm Referenced Policy Set for Healthcare Professionals with Delegation (304) template | active | 2025-05 | ch | ietf | ||
ch.fhir.ig.ch-epr-fhir | R4 | PpqmReferencedPolicySetFullAccess | CH PPQm Referenced Policy Set for Patients (201) and Representative (303) templates | active | 2025-05 | ch | ietf | ||
ch.fhir.ig.ch-epr-fhir | R4 | PpqmReferencedPolicySetGroupEmergency | CH PPQm Referenced Policy Set for Emergency Access (202) and HCP Group (302) templates | active | 2025-05 | ch | ietf | ||
ch.fhir.ig.ch-epr-ppqm | R4 | PpqmReferencedPolicySet | PPQm Referenced Policy Set | active | 2023-12 | ch | ietf | ||
ch.fhir.ig.ch-epr-fhir | R4 | PpqmPolicySetTemplateId | CH PPQm Policy Set Template ID | active | 2025-05 | ch | internal | ||
ch.fhir.ig.ch-epr-ppqm | R4 | PpqmPolicySetTemplateId | PPQm Policy Set Template ID | active | 2023-12 | ch | internal | ||
hl7.fhir.dk.core | R4 | dk-core-IEEEBasicObservation | Dk Core IEEE Basic Observation | active | 2025-02 | dk | iso | ||
ch.fhir.ig.ch-term | R4 | ihe-pharmaceuticaladvicestatuslist | IHE Pharmaceutical Advice Status List | active | 2025-05 | ch | oid | ||
hl7.fhir.us.vr-common-library | R4 | ValueSet-ije-vr | ValueSet - Placeholder ValueSet for Interjurisdictional Exchange (IJE) in Vital Records | active | pher | 2025-05 | us | fhir | |
hl7.terminology | R5 | v3-TribalEntityUS | TribalEntityUS | active | 2014-03 | uv | tho | ||
hl7.cda.uv.ips | R4 | 2.16.840.1.113883.11.22.3--20240802092105 | IPS Allergy Reaction | draft | 2024-08 | uv | sct | ||
hl7.cda.uv.ips | R4 | 2.16.840.1.113883.11.22.42--20170524000000 | IPS Allergy Status Code | draft | 2024-08 | uv | fhir | ||
hl7.cda.uv.ips | R4 | 2.16.840.1.113883.11.22.62--20180207120421 | IPS Allergy Verification Status | draft | 2024-08 | uv | fhir | ||
hl7.cda.uv.ips | R4 | 2.16.840.1.113883.11.22.10--20240802091633 | IPS Allergy or Intolerance Conditions | draft | 2024-08 | uv | sct | ||
hl7.cda.uv.ips | R4 | 2.16.840.1.113883.11.22.65--20240802091315 | IPS Allergy or Intolerance Substances | draft | 2024-08 | uv | sct | ||
OntarioacCDRFHIRImplementationGuide-0.10.00 | R4 | allergy-intolerance-substance-condition-gps-uv-ips | Allergy intolerance substance condition (GPS) - IPS | active | 2020-05 | ca | sct | ||
fhir.tx.support.r4 | R4 | allergy-intolerance-substance-product-snomed-extended-uv-ips | Allergy intolerance substance product - SNOMED CT extended - IPS | active | 2021-05 | us | sct | ||
OntarioacCDRFHIRImplementationGuide-0.10.00 | R4 | allergy-reaction-gps-uv-ips | Allergy Reaction (GPS) - IPS | active | 2020-05 | ca | sct | ||
fhir.tx.support.r4 | R4 | allergy-intolerance-substance-product-gps-uv-ips | Allergy-intolerance substance-product - GPS - IPS | active | 2021-05 | us | sct | ||
hl7.cda.uv.ips | R4 | 2.16.840.1.113883.11.22.8--20170329000000 | IPS Condition Verification Status | draft | 2024-08 | uv | fhir | ||
hl7.fhir.uv.ips | R4 | diagnostics-report-status-uv-ips | Diagnostics Report Status Codes - IPS | trial-use | 2 | pc | 2025-05 | uv | fhir |
hl7.fhir.uv.ips | R4 | edd-method-uv-ips | Pregnancy Expected Delivery Date Method - IPS | trial-use | 2 | pc | 2025-05 | uv | loinc |
hl7.cda.uv.ips | R4 | 2.16.840.1.113883.11.22.72--20240802094107 | IPS Pregnancy Expected Delivery Date Method | draft | 2024-08 | uv | loinc | ||
hl7.fhir.uv.ips | R4 | healthcare-professional-roles-uv-ips | Healthcare Professional Roles - IPS | trial-use | 2 | pc | 2025-05 | uv | oid |
hl7.cda.uv.ips | R4 | 2.16.840.1.113883.11.22.53--20170621000000 | IPS Healthcare Professional Roles | draft | 2024-08 | uv | oid | ||
hl7.fhir.uv.ips | R4 | imaging-study-status-uv-ips | Imaging Study Status Codes - IPS | trial-use | 2 | pc | 2025-05 | uv | fhir |
hl7.fhir.uv.ips | R4 | medical-devices-uv-ips | Medical Devices - IPS | trial-use | 2 | pc | 2025-05 | uv | sct |
hl7.cda.uv.ips | R4 | 2.16.840.1.113883.11.22.71--20240802094107 | IPS Medications Products | draft | 2024-08 | uv | sct | ||
hl7.fhir.uv.ips | R4 | medication-uv-ips | Medications - IPS | trial-use | 2 | pc | 2025-05 | uv | sct |
hl7.fhir.uv.ips | R4 | medicine-active-substances-uv-ips | Medicine Active Substances - IPS | trial-use | 2 | pc | 2025-05 | uv | sct |
hl7.fhir.uv.ips | R4 | results-status-uv-ips | Results Status Codes - IPS | trial-use | 2 | pc | 2025-05 | uv | fhir |
HIE2.packages | R4 | result-coded-value-pathology-gps-uv-ips | Results Coded Values Pathology (GPS) - IPS | active | 2022-01 | uv | sct | ||
hl7.fhir.uv.ips | R4 | pregnancies-summary-uv-ips | Pregnancy Outcome - IPS | trial-use | 2 | pc | 2025-05 | uv | loinc |
hl7.cda.uv.ips | R4 | 2.16.840.1.113883.11.22.21--20170413000000 | IPS Pregnancies Summary | draft | 2024-08 | uv | loinc | ||
hl7.fhir.uv.ips | R4 | problems-uv-ips | Problems - IPS | trial-use | 2 | pc | 2025-05 | uv | sct |
hl7.cda.uv.ips | R4 | 2.16.840.1.113883.11.22.73--20240802094107 | IPS Problems | draft | 2024-08 | uv | sct | ||
hl7.fhir.uv.ips | R4 | procedures-uv-ips | Procedures - IPS | trial-use | 2 | pc | 2025-05 | uv | sct |
hl7.fhir.uv.ips | R4 | results-coded-values-laboratory-pathology-uv-ips | Results Coded Values Laboratory/Pathology - IPS | trial-use | 2 | pc | 2025-05 | uv | sct |
hl7.cda.uv.ips | R4 | 2.16.840.1.113883.11.22.38--20170523000000 | IPS Results Observation | draft | 2024-08 | uv | loinc | ||
hl7.cda.uv.ips | R4 | 2.16.840.1.113883.11.22.37--20170523000000 | IPS Results Organizer | draft | 2024-08 | uv | loinc | ||
hl7.fhir.uv.ips | R4 | results-radiology-txtobs-uv-ips | Results Radiology Textual Observation - IPS | trial-use | 2 | pc | 2025-05 | uv | sct loinc dcm |
hl7.cda.uv.ips | R4 | 2.16.840.1.113883.11.22.66--20240802105026 | IPS Results Radiology Textual Observations | draft | 2024-08 | uv | sct loinc dcm | ||
HIE2.packages | R4 | results-radiology-txtobs-gps-dicom-loinc-uv-ips | Results Radiology Textual Observations (GPS-DICOM-LOINC) - IPS | active | 2022-01 | uv | sct loinc dcm | ||
hl7.cda.uv.ips | R4 | 2.16.840.1.113883.11.22.76--20240802105320 | IPS Results Specimen Collection Method | draft | 2024-08 | uv | sct | ||
HIE2.packages | R4 | results-specimen-collection-method-gps-uv-ips | Results Specimen Collection Method (GPS) - IPS | active | 2022-01 | uv | sct | ||
HIE2.packages | R4 | results-specimen-type-gps-uv-ips | Results Specimen Type (GPS) - IPS | active | 2022-01 | uv | sct | ||
hl7.cda.uv.ips | R4 | 2.16.840.1.113883.11.22.56--20240802105507 | IPS Specimen Type | draft | 2024-08 | uv | sct | ||
hl7.fhir.uv.ips | R4 | results-specimen-type-uv-ips | Results Specimen Type - IPS | trial-use | 2 | pc | 2025-05 | uv | sct |
hl7.fhir.uv.ips | R4 | results-specimen-collection-method-uv-ips | Results Specimen Collection Method - IPS | trial-use | 2 | pc | 2025-05 | uv | sct |
hl7.fhir.uv.ips | R4 | vaccines-uv-ips | Vaccines - IPS | trial-use | 2 | pc | 2025-05 | uv | sct |
hl7.fhir.uv.ips | R4 | vaccines-whoatc-uv-ips | Vaccines WHO ATC - IPS | trial-use | 2 | pc | 2025-05 | uv | atc |
hl7.fhir.uv.ips | R4 | target-diseases-uv-ips | Vaccine Target Diseases - IPS | trial-use | 2 | pc | 2025-05 | uv | sct |
hl7.fhir.uv.ips | R4 | allergies-intolerances-uv-ips | Allergies & Intolerances - IPS | trial-use | 2 | pc | 2025-05 | uv | sct |
hl7.fhir.uv.ips | R4 | allergy-reaction-uv-ips | Allergy Reaction - IPS | trial-use | 2 | pc | 2025-05 | uv | sct |
hl7.cda.uv.ips | R4 | 2.16.840.1.113883.11.22.55--20240802093131 | IPS Body Site | draft | 2024-08 | uv | sct | ||
hl7.fhir.uv.ips | R4 | body-site-uv-ips | Body Site - IPS | trial-use | 2 | pc | 2025-05 | uv | sct |
hl7.fhir.uv.ips | R4 | pregnancy-status-uv-ips | Pregnancy Status - IPS | trial-use | 2 | pc | 2025-05 | uv | sct |
hl7.fhir.eu.base-r5 | R5 | iso-ehicCountryCode | ISO 3166 - EHIC Country Codes | draft | 2025-05 | eu | iso | ||
hl7.fhir.eu.base | R4 | iso-ehicCountryCode | ISO 3166 - EHIC Country Codes | draft | 2025-05 | eu | iso | ||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.20.5.2--20200901000000 | LandISOCodelijst | active | nl | iso | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.20.5.2--20171231000000 | LandISOCodelijst | active | nl | iso | |||
hl7.fhir.us.insurance-card | R4 | ISOColorVS | C4DIC ISO Color | active | claims | 2024-04 | us | tho | |
hl7.fhir.uv.emedicinal-product-info | R5 | country | ISO Country two letter code | active | 2025-07 | uv | tho | ||
hl7.fhir.uv.emedicinal-product-info | R5 | language | ISO language two letter code | active | 2025-07 | uv | fhir | ||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.12.2--20200901000000 | CommunicatieTaalCodelijst | active | nl | oid | |||
hl7.fhir.it.lab-report | R4 | istat-cittadinanza | ISTAT - Cittadinanza | active | 2024-03 | it | internal | ||
hl7.fhir.it.lab-report | R4 | istat-luogoNascita | ISTAT - Comune/Stato di Nascita | active | 2024-03 | it | internal | ||
hl7.fhir.it.lab-report | R4 | istat-comune | ISTAT - Comuni | active | 2024-03 | it | internal tho | ||
hl7.fhir.it.lab-report | R4 | istat-professione | ISTAT - Professioni | active | 2024-03 | it | internal | ||
hl7.fhir.it.lab-report | R4 | istat-provincia | ISTAT - Province | active | 2024-03 | it | internal tho | ||
hl7.fhir.it.lab-report | R4 | istat-dug | ISTAT - DUG | active | 2024-03 | it | internal | ||
hl7.fhir.it.lab-report | R4 | istat-stato | ISTAT - Stati | active | 2024-03 | it | internal | ||
hl7.fhir.it.terminology | R4 | istat-statoCivile-vs | ISTAT - Stato Civile | active | 2025-06 | it | internal | ||
hl7.fhir.it.lab-report | R4 | istat-statoCivile-vs | ISTAT - Stato Civile | active | 2024-03 | it | internal | ||
hl7.fhir.it.lab-report | R4 | istat-titoloStudio | ISTAT - Titolo Studio | active | 2024-03 | it | internal | ||
de.gematik.isik | R4 | ISiKEntlassformReha | ISiKEntlassformRehaVS | active | 2025-06 | de | |||
de.gematik.isik | R4 | ISiKMedikationsartVS | ISiKMedikationsartVS | active | 2025-06 | de | |||
de.gematik.isik | R4 | ISiKUnterbrechungReha | ISiKUnterbrechungRehaVS | active | 2025-06 | de | |||
hl7.fhir.uv.livd | R4 | livd-device-type | IVD device types for LIVD device definitions | draft | oo | 2024-12 | uv | fhir | |
hl7.fhir.cl.minsal.nid | R4 | VSIdentidadDeGenero | Identidad De Género | active | 2023-01 | cl | internal | ||
hl7.fhir.sami.core | R4 | Human_gender | Gênero | active | 2022-02 | sami | |||
hl7.fhir.cl.recetachile | R4 | VSTipoPrescripcion | Tipo de Prescripción | active | 2022-01 | cl | internal | ||
hl7.fhir.cl.minsal.nid | R4 | VSIdentificadorPrestador | Identificador del Prestador | active | 2023-01 | cl | |||
hl7.fhir.uv.VulcanUdpIg | R4 | sponsor-identifier-vs | Sponsor Identifier Value Set | draft | 2025-05 | uv | fhir | ||
hl7.fhir.uv.pharmaceutical-research-protocol | R6 | m11-identifier-type-vs | M11 Identifier Type Value Set | informative | brr | 2025-07 | uv | ncit | |
hl7.fhir.it.lab-report | R4 | uri-idEni | Identificativi per codici ENI regionali | active | 2024-03 | it | ietf | ||
hl7.fhir.it.terminology | R4 | URI-idStp | Identificativi per codici STP regionali | active | 2025-06 | it | ietf | ||
hl7.fhir.it.lab-report | R4 | URI-idStp | Identificativi per codici STP regionali | active | 2024-03 | it | ietf | ||
hl7.fhir.it.terminology | R4 | uri-idAslRegione | Identificativi regionali per ASL (3 char) | active | 2025-06 | it | ietf | ||
hl7.fhir.it.lab-report | R4 | uri-idAslRegione | Identificativi regionali per ASL (3 char) | active | 2024-03 | it | ietf | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.10.20.22.5.304 | Organism | active | 2024-06 | us | sct | ||
fhir.virtually.healthcare | R4 | IdentifierTypeVH | Identifier Type | draft | 2025-07 | us | tho | ||
fhir.mamaToto | R4 | identifierTypesVS | Identifier Types ValueSet | draft | 2025-06 | us | internal | ||
ee.fhir.terminology | R5 | organization-identifier-domain | Organization Identifier Domain | active | 2025-06 | ee | internal | ||
ee.fhir.terminology | R5 | practitioner-identifier-domain | Practitioner Identifier Domain | active | 2025-06 | ee | internal | ||
hl7.terminology | R5 | artifact-identifier-type | Artifact Identifier Type | active | cqi | 2024-02 | uv | tho | |
hl7.fhir.us.davinci-cdex | R4 | cdex-identifier-types | CDex Identifier Types Value Set | trial-use | 2 | claims | 2022-10 | us | tho |
hl7.fhir.au.base | R4 | accession-number-type | Accession Number Type | trial-use | 1 | 2025-06 | au | tho | |
hl7.fhir.au.base | R4 | order-identifier-type | Order Identifier Type | trial-use | 1 | 2025-06 | au | tho | |
fhir.nw-gmsa.nhs.uk | R4 | NWIdentifierType | NW IdentifierType | draft | 2025-04 | us | tho | ||
hl7.fhir.uv.cardx-cied | R5 | cied-patient-identifier | CIED Patient Identifier | trial-use | 2 | cic | 2025-07 | uv | fhir tho |
hl7.terminology | R5 | v3-ObservationActContextAgeGroupType | ObservationActContextAgeGroupType | active | 2010-03 | uv | loinc | ||
hl7.terminology | R5 | v3-LOINCObservationActContextAgeDefinitionCode | LOINCObservationActContextAgeDefinitionCode | active | 2010-03 | uv | loinc | ||
hl7.terminology | R5 | v3-RelationalOperator | RelationalOperator | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-CodingRationale | CodingRationale | active | 2014-03 | uv | tho | ||
hl7.fhir.us.carin-bb | R4 | C4BBRelatedClaimRelationshipCodes | C4BB Related Claim Relationship Codes Value Set | trial-use | fm | 2025-02 | us | fhir tho | |
signal.core.r4 | R4 | questionnaire-ccars-medication-psychiatric-service | Questionnaire CCARS Medication Psychiatric Service | draft | 1 | pa | us | ||
hl7.cda.examples | R5 | ApprovalStatusValueSet | Example Approval Status | active | 2025-07 | examples | internal | ||
signal.core.r4 | R4 | questionnaire-dacods-health-insurance-status | Questionnaire DACODS Health Insurance Status | draft | 1 | pa | us | ||
signal.core.r4 | R4 | questionnaire-dacods-drug-type-code | Questionnaire DACODS Drug Type Code | draft | 1 | pa | us | ||
signal.core.r4 | R4 | questionnaire-dacods-source-of-income | Questionnaire DACODS Source Of Income | draft | 1 | pa | us | ||
signal.core.r4 | R4 | questionnaire-dacods-secondary-tertiary-drug-type-code | Questionnaire DACODS Secondary Tertiary Drug Type Code | draft | 1 | pa | us | ||
signal.core.r4 | R4 | questionnaire-dacods-employment-status | Questionnaire DACODS Employment Status | draft | 1 | pa | us | ||
signal.core.r4 | R4 | questionnaire-dacods-transfer-referral-source | Questionnaire DACODS Transfer Referral Source | draft | 1 | pa | us | ||
signal.core.r4 | R4 | questionnaire-dacods-clinician-diagnostic-impression | Questionnaire DACODS Clinician Diagnostic Impression | draft | 1 | pa | us | ||
signal.core.r4 | R4 | questionnaire-dacods-medical-physical-problems | Questionnaire DACODS Medical Physical Problems | draft | 1 | pa | us | ||
signal.core.r4 | R4 | questionnaire-dacods-education-employment-problems | Questionnaire DACODS Education Employment Problems | draft | 1 | pa | us | ||
signal.core.r4 | R4 | questionnaire-dacods-family-issues-and-problems | Questionnaire DACODS Family Issues And Problems | draft | 1 | pa | us | ||
signal.core.r4 | R4 | questionnaire-dacods-socialization-problems | Questionnaire DACODS Socialization Problems | draft | 1 | pa | us | ||
hl7.terminology | R5 | v3-DocumentCompletion | DocumentCompletion | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActInvoiceElementSummaryCode | ActInvoiceElementSummaryCode | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | research-subject-state-type | ResearchSubjectStateType | active | 1 | brr | 2024-04 | uv | tho |
hl7.terminology | R5 | v3-ObservationType | ObservationType | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | questionnaire-usage-mode | QuestionnaireItemUsageMode | draft | fhir | 2020-02 | uv | tho | |
hl7.terminology | R5 | v3-ParticipationMode | ParticipationMode | active | 2014-03 | uv | tho | ||
signal.core.r4 | R4 | questionnaire-dacods-source-of-payment-for-treatment | Questionnaire DACODS Source Of Payment For Treatment | draft | 1 | pa | us | ||
signal.core.r4 | R4 | identifier-use | IdentifierUse | draft | 0 | fhir | 2019-10 | us | fhir |
hl7.terminology | R5 | v3-ActIneligibilityReason | ActIneligibilityReason | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActAccommodationReason | ActAccommodationReason | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ParticipationTypeCDASectionOverride | ParticipationTypeCDASectionOverride | active | 2014-03 | uv | tho | ||
signal.core.r4 | R4 | questionnaire-dacods-sexual-orientation | Questionnaire DACODS Sexual Orientation | draft | 1 | pa | us | ||
hl7.terminology | R5 | v3-MedicationGeneralizationRoleType | MedicationGeneralizationRoleType | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-DocumentStorage | DocumentStorage | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-QueryPriority | QueryPriority | active | 2014-03 | uv | tho | ||
hl7.fhir.us.insurance-card | R4 | C4DICCoverageIdentifierType | C4DIC Coverage Identifier Type | active | claims | 2024-04 | us | fhir tho | |
hl7.fhir.us.carin-bb | R4 | C4BBPatientIdentifierType | C4BB Patient Identifier Type Value Set | trial-use | fm | 2025-02 | us | fhir tho |